Hantavirus Panic and the Media’s Outbreak Attention Problem

Hantavirus is having a media moment again. First came the death of Betsy Arakawa, wife of actor Gene Hackman, from hantavirus pulmonary syndrome. That was soon forgotten. Then came intense coverage of a suspected cluster aboard a cruise ship traveling from Argentina toward Cape Verde. Suddenly, headlines and cable segments began treating hantavirus as if it were poised to become the next major global infectious threat.

As someone who has spent the last several days doing television, radio, podcast, and print interviews on hantavirus, I’ve repeatedly found myself trying to inject proportionality into the conversation. The challenge has not been convincing journalists that hantavirus is serious — it can be — but rather helping audiences understand what kind of threat it actually represents, and what kind it does not.

Because this reaction says more about how modern media ecosystems process infectious disease stories than it does about the actual public health risk posed by hantavirus.

Hantaviruses are real, serious pathogens. In the Americas, they can cause hantavirus pulmonary syndrome, a severe respiratory illness with a high case fatality rate. However, they are also exceedingly rare. Since surveillance began in 1993, the United States has documented fewer than 1,000 total cases. Most cases occur after direct or indirect exposure to rodent droppings in rural environments — cabins, sheds, barns, crawl spaces, and other enclosed settings where deer mice live.

That epidemiology matters.

Unlike influenza, measles, SARS-CoV-2, or norovirus, hantavirus is not efficiently transmitted person-to-person in the United States. It lacks the characteristics that allow respiratory viruses to sustain large outbreaks in human populations. Even in South America, where limited human-to-human transmission has occasionally been documented with the Andes strain, spread is uncommon and typically requires close contact.

Yet the media response often strips away that nuance. Rare diseases with dramatic clinical presentations tend to generate disproportionate attention because they satisfy several conditions modern news systems reward: novelty, mystery, severity, and emotional salience. A virus with a 30–40% fatality rate sounds terrifying, even if the average person’s probability of exposure is extraordinarily low.

The same pattern occurs with public health response language. During outbreak investigations, media reports will often breathlessly note that the CDC has activated at “Level 3,” without explaining what that actually means. To many readers, “Level 3 activation” sounds ominous — as though the agency is escalating toward emergency footing. In reality, CDC emergency activations are inverted from how most people intuitively think about them: Level 1 is the highest, most serious activation, while Level 3 is the lowest level of activation and often reflects a relatively modest operational response. Omitting that context can unintentionally magnify public fear and create the impression that officials view the situation as far more dangerous than they actually do. There are different levels of public health emergencies and not all constitute epidemic —let alone pandemic — threats

This dynamic is amplified by the post-COVID information environment. Both journalists and the public are now primed to interpret any unusual infectious disease event almost exclusively through a pandemic lens. A cruise ship cluster becomes framed less as an epidemiologic investigation and more as a possible origin story for “the next pandemic.” That framing may drive clicks and engagement, but it can distort public understanding of risk.

The irony is that many much larger infectious disease threats struggle to command sustained attention. Seasonal influenza kills thousands annually. Drug-resistant bacterial infections steadily expand. Measles outbreaks are re-emerging because of declining vaccination rates. Tick-borne illnesses continue to rise across the United States. These problems are epidemiologically far more important to the average person than hantavirus.

Part of the issue is that public perception of risk is not calibrated by statistical probability. It is calibrated by imagery, narrative, and fear. Rodent-borne viruses on remote cruise ships feel cinematic. Endemic respiratory viruses do not.

None of this means hantavirus should be ignored. Clinicians should recognize it. Public health officials should investigate clusters aggressively. Situations like the cruise ship outbreak require adept epidemiologic investigation, careful risk communication, and thoughtful operational management in order to protect passengers while avoiding unnecessary panic. Rodent control and environmental hygiene matter. But proportionality matters too.

One of the most important functions infectious disease experts can serve in media appearances is not simply explaining pathogens, but calibrating risk. Sometimes that means sounding alarms. Other times it means lowering the temperature. In the case of hantavirus, the latter is often what is needed most.

One of the central challenges in infectious disease communication is helping people distinguish between a dangerous pathogen and a civilization-altering one. The question is not simply whether a pathogen is dangerous. The question is when to worry — and why.

Infectious disease reporting works best when it informs rather than startles — when it contextualizes risk instead of merely amplifying anxiety. Hantavirus is a fascinating virus and an important pathogen. It is not, however, civilization’s next existential microbial threat.